Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)
China
· Delayed Price · Currency is CNY 6.75
-0.36 (-5.06%)
Apr 30, 2026, 3:04 PM CST
SHE:002581 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | -160.83 | -137.31 | -332.46 | -14.68 | 271 | Upgrade
|
| Depreciation & Amortization | 38.49 | 41.67 | 70.63 | 74.86 | 65.9 | Upgrade
|
| Other Amortization | 0.15 | 1.09 | 4.41 | 2.59 | 3.55 | Upgrade
|
| Loss (Gain) From Sale of Assets | -3.82 | -1.16 | 6.33 | -0.05 | 0.15 | Upgrade
|
| Asset Writedown & Restructuring Costs | 43.65 | 69.64 | 293.88 | 13.61 | 0.48 | Upgrade
|
| Loss (Gain) From Sale of Investments | -23.91 | -44.08 | -172.68 | -217.45 | -471.94 | Upgrade
|
| Provision & Write-off of Bad Debts | - | -4.73 | -27.56 | -3.48 | -2.2 | Upgrade
|
| Other Operating Activities | 17.96 | 10.02 | 39.07 | 22.87 | 21.01 | Upgrade
|
| Change in Accounts Receivable | -230.18 | 67.81 | 69.76 | 2.45 | 75.08 | Upgrade
|
| Change in Inventory | 20.82 | -9.34 | -15.16 | -16.13 | 6.53 | Upgrade
|
| Change in Accounts Payable | 30.57 | 11.35 | 6.24 | 68.51 | -15.39 | Upgrade
|
| Change in Other Net Operating Assets | 29.28 | -8.31 | 15.5 | - | - | Upgrade
|
| Operating Cash Flow | -253.73 | -6.55 | -36.51 | -54.49 | -46.02 | Upgrade
|
| Capital Expenditures | -179.7 | -9.01 | -4.32 | -31.46 | -60.85 | Upgrade
|
| Sale of Property, Plant & Equipment | 4.07 | 8.17 | 4.77 | 24.45 | 0.02 | Upgrade
|
| Divestitures | - | 73.75 | - | - | - | Upgrade
|
| Investment in Securities | - | - | 0.03 | -28 | 5 | Upgrade
|
| Other Investing Activities | 143.02 | 294.16 | 256.17 | -3.4 | - | Upgrade
|
| Investing Cash Flow | -32.61 | 367.06 | 256.65 | -38.42 | -55.83 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 227.5 | 218 | Upgrade
|
| Long-Term Debt Issued | 8 | 2.77 | 13.84 | 62.95 | - | Upgrade
|
| Total Debt Issued | 8 | 2.77 | 13.84 | 290.45 | 218 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -229 | -188 | Upgrade
|
| Long-Term Debt Repaid | -19.78 | -10.56 | -214.7 | -13.39 | -25.3 | Upgrade
|
| Total Debt Repaid | -19.78 | -10.56 | -214.7 | -242.39 | -213.3 | Upgrade
|
| Net Debt Issued (Repaid) | -11.78 | -7.79 | -200.87 | 48.06 | 4.7 | Upgrade
|
| Common Dividends Paid | -1.14 | -0.18 | -10.28 | -8.04 | -6.71 | Upgrade
|
| Other Financing Activities | -1.12 | - | - | 7.88 | 7.49 | Upgrade
|
| Financing Cash Flow | -14.03 | -7.97 | -211.14 | 47.89 | 5.49 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0 | 0 | -0 | 0 | -0 | Upgrade
|
| Net Cash Flow | -300.37 | 352.54 | 9 | -45 | -96.35 | Upgrade
|
| Free Cash Flow | -433.43 | -15.56 | -40.82 | -85.95 | -106.86 | Upgrade
|
| Free Cash Flow Margin | -157.72% | -4.32% | -9.50% | -24.07% | -26.53% | Upgrade
|
| Free Cash Flow Per Share | -0.66 | -0.02 | -0.06 | -0.13 | -0.16 | Upgrade
|
| Cash Income Tax Paid | 15.63 | 22.6 | 31.75 | 15.49 | 20.31 | Upgrade
|
| Levered Free Cash Flow | -337.55 | 32.36 | -107.84 | 85.69 | 1.83 | Upgrade
|
| Unlevered Free Cash Flow | -337.55 | 32.49 | -102.18 | 91.57 | 6.13 | Upgrade
|
| Change in Working Capital | -165.42 | 58.32 | 81.88 | 67.26 | 66.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.